| Systematic analysis of microRNA fingerprints in thrombocythemic platelets using integrated platforms. Xu X., Gnatenko D.V., Ju J., Hitchcock I.S., Martin D.W., Zhu W., Bahou W.F.
Blood 120:3575-3585(2012) · Mapped (3) |
| ERK1/2 activation in heart is controlled by melusin, focal adhesion kinase and the scaffold protein IQGAP1. Sbroggio M., Bertero A., Velasco S., Fusella F., De Blasio E., Bahou W.F., Silengo L., Turco E., Brancaccio M., Tarone G.
J. Cell. Sci. 124:3515-3524(2011) · Mapped (17) |
| Ablation of Iqgap2 protects from diet-induced hepatic steatosis due to impaired fatty acid uptake. Chiariello C.S., LaComb J.F., Bahou W.F., Schmidt V.A.
Regul. Pept. 173:36-46(2012) · Mapped (7) |
| IQGAP1 regulates ERK1/2 and AKT signalling in the heart and sustains functional remodelling upon pressure overload. Sbroggio M., Carnevale D., Bertero A., Cifelli G., De Blasio E., Mascio G., Hirsch E., Bahou W.F., Turco E., Silengo L. et al.
Cardiovasc. Res. 91:456-464(2011) · Mapped (19) |
| IQGAP1 is involved in post-ischemic neovascularization by regulating angiogenesis and macrophage infiltration. Urao N., Razvi M., Oshikawa J., McKinney R.D., Chavda R., Bahou W.F., Fukai T., Ushio-Fukai M.
PLoS ONE 5:e13440-e13440(2010) · Mapped (12) |
| Altered bioavailability of platelet-derived factor VIII during thrombocytosis reverses phenotypic efficacy in haemophilic mice. Damon A.L., Scudder L.E., Gnatenko D.V., Sitaraman V., Hearing P., Jesty J., Bahou W.F.
Thromb. Haemost. 100:1111-1122(2008) · Mapped (15) |
| Development of hepatocellular carcinoma in Iqgap2-deficient mice is IQGAP1 dependent. Schmidt V.A., Chiariello C.S., Capilla E., Miller F., Bahou W.F.
Mol. Cell. Biol. 28:1489-1502(2008) · Mapped (20) |
| Platelets express steroidogenic 17beta-hydroxysteroid dehydrogenases. Distinct profiles predict the essential thrombocythemic phenotype. Gnatenko D.V., Cupit L.D., Huang E.C., Dhundale A., Perrotta P.L., Bahou W.F.
Thromb. Haemost. 94:412-421(2005) · UniProtKB (1) |
| Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells. Cupit L.D., Schmidt V.A., Gnatenko D.V., Bahou W.F.
Exp. Hematol. 32:991-999(2004) · Mapped (2) |
| Distinct PAR/IQGAP expression patterns during murine development: implications for thrombin-associated cytoskeletal reorganization. Cupit L.D., Schmidt V.A., Miller F., Bahou W.F.
Mamm. Genome 15:618-629(2004) · Mapped (27) |
| A shear-restricted pathway of platelet procoagulant activity is regulated by IQGAP1. Bahou W.F., Scudder L., Rubenstein D., Jesty J.
J. Biol. Chem. 279:22571-22577(2004) · Mapped (13) |
| IQGAP2 functions as a GTP-dependent effector protein in thrombin-induced platelet cytoskeletal reorganization. Schmidt V.A., Scudder L., Devoe C.E., Bernards A., Cupit L.D., Bahou W.F.
Blood 101:3021-3028(2003) · Mapped (5) |
| The human proteinase-activated receptor-3 (PAR-3) gene. Identification within a PAR gene cluster and characterization in vascular endothelial cells and platelets. Schmidt V.A., Nierman W.C., Maglott D.R., Cupit L.D., Moskowitz K.A., Wainer J.A., Bahou W.F.
J. Biol. Chem. 273:15061-15068(1998) · UniProtKB (1) |
| Permissive role of nitric oxide in endothelin-induced migration of endothelial cells. Noiri E., Hu Y., Bahou W.F., Keese C.R., Giaever I., Goligorsky M.S.
J. Biol. Chem. 272:1747-1752(1997) |
| Genomic cloning and characterization of the human thrombin receptor gene. Structural similarity to the proteinase activated receptor-2 gene. Schmidt V.A., Vitale E., Bahou W.F.
J. Biol. Chem. 271:9307-9312(1996) · Mapped (2) |
| Chromosomal assignment of the human thrombin receptor gene: localization to region q13 of chromosome 5. Bahou W.F., Nierman W.C., Durkin A.S., Potter C.L., Demetrick D.J.
Blood 82:1532-1537(1993) · Mapped (8) |
| The VLA-2 (alpha 2 beta 1) I domain functions as a ligand-specific recognition sequence for endothelial cell attachment and spreading: molecular and functional characterization. Bahou W.F., Potter C.L., Mirza H.
Blood 84:3734-3741(1994) · UniProtKB (1) |
| The molecular defect in type IIB von Willebrand disease. Identification of four potential missense mutations within the putative GpIb binding domain. Cooney K.A., Nichols W.C., Bruck M.E., Bahou W.F., Shapiro A.D., Bowie E.J.W., Gralnick H.R., Ginsburg D.
J. Clin. Invest. 87:1227-1233(1991) · UniProtKB (1) |
| cDNA cloning and molecular characterization of MSE55, a novel human serum constituent protein that displays bone marrow stromal/endothelial cell-specific expression. Bahou W.F., Campbell A.D., Wicha M.S.
J. Biol. Chem. 267:13986-13992(1992) · UniProtKB (1) |
